Oculus Innovative Sciences (OCLS) Misses Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Oculus Innovative Sciences Reports Financial Results for the First Quarter of Fiscal Year 2016
July 30, 2015 4:05 PM EDTU.S. dermatology and Latin American sales drive 37% product revenue growth FDA 510k clearance for treatment of atopic dermatitis with a unique "no touch" spray gel Cash as of June 30, 2015 of $8.8 million and debt free
Conference call begins at 4:30 p.m. EDT today
PETALUMA, Calif., July 30, 2015 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) (tradable warrants OCLSW) today announced financial results for the first quarter of fiscal year 2016, which ended on June 30, 2015. Total... More
